Serotonergic receptors modify the voluntary intake of alcohol and morphine but not of cocaine and nicotine by rats

Pharmacology

Volumn 54, Issue 4, 1997, Pages 186-192

  Mosner, Alexander ^a   Kuhlman, Gabriele ^a   Roehm, Cordula ^a   Vogel, Wolfgang H ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

5 HT1A receptors; Alcohol; Cocaine; Drug preference; Fluvoxamine; Ipsapirone; Morphine; Nicotine; Serotonin

Indexed keywords

ALCOHOL; COCAINE; FLUVOXAMINE; IPSAPIRONE; MORPHINE; NICOTINE; SEROTONIN 1A RECEPTOR; SEROTONIN RECEPTOR;

ALCOHOL CONSUMPTION; ANIMAL EXPERIMENT; ARTICLE; BRAIN; CONTROLLED STUDY; DRUG ABUSE; DRUG DESIGN; DRUG USE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; RECEPTOR BINDING; SEROTONINERGIC SYSTEM;

EID: 0030925461     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000139486     Document Type: Article

References (36)

1. Naranjo CA, Brcmner KE: Clinical pharmacology of serotonin-altering medications for decreasing alcohol consumption. Alcohol Alcohol Suppl 1993;2:221-229.
2. LeMarquand D, Phil RO. Benkclfet C: Serotonin and alcohol intake, abuse, and dependence: Findings of animal studies. Biol Psychiatry 1994;36:395-421.
3. Meert TF: Effects of various serotonergic agents on alcohol intake and alcohol preference in Wistar rats selected at two different levels of alcohol preference. Alcohol Alcohol 1993:28:157-170.
4. Chen CC. Fujiwara Y, Akiyoma K, Ujikc H, Moriya F, Otsuki S: Voluntary intake of alcohol is attenuated by ipsapirone in mice and role of the 5-HT1A receptor. Jpn J Psychiatry Neurol 1992:46:197-203.
5. Wilde CH. Vogel WH: Influence of the 5-HT1A receptor agonist ipsapi-ronc on voluntary alcohol intake in rats. Alcohol 1994;11:411-415.
6. Knapp DJ. Pohorecky LA: Effect of the 5-HT1A agonist gepirone on alcohol intake in the rat during restricted access. Alcohol Clin Exp Res 1991:14:304-311.
7. Collins DM. Myers RD: Buspirone attenuates volitional alcohol intake in chronically drinking monkeys. Alcohol 1987:4:49-56.
8. Schreibcr R, Opitz K, Glaser T. DeVry J: Ipsapirone and 8-OH-DPAT reduce ethanol preference in rats. Psychopharmacology 1993: 112:100-110.
9. Rockman GE, Amit Z, Brown ZW. Bourque C. Oegrcn SO: An investigation of the mechanism of action of 5-HT in the suppression of ethanol intake. Neuropharmacology 1982; 21:341-347.
10. Reibero EB. Bettikcr RL, Bogdanov M. Wurtman RJ: Effects of systemic nicotine on serotonin release in rat brain. Brain Res 1993:621:311-318.
11. Roberts DC, Loh EA. Baker GB. Vickers G: Lesions of central serotonin systems affect responding on a progressive ratio schedule reinforced either by intravenous cocaine or by food. Pharmacol Biochem Bc-hav 1994;49:177-182.
12. Peltier R. Schenk S: Effects of serotonergic manipulations on cocaine self-administration in rats. Psychopharmacology 1993:110:390-394.
13. Alhaider AA, Wilcox GL: Differential roles of 5-hydroxytryptaminc IA and 5-hydroxytryptamine IB receptor subtypes in modulating spinal nociceptive transmission in mice. J Pharmacol Exp Titer 1993: 265:378-385.
14. Battaglia G, Cabrera TM, Van de Kar LDP: Prenatal cocaine produces biochemical and functional changes in brain serotonin systems in rat progeny. NIDA Res Monogr 1995;158:115-148.
15. Sattel SL. Kristal JH. Delgado PL, Kostcn TR. Chamcy DS: Tryptophan depletion and attenuation of cue-induced craving for cocaine. Am J Psychiatry 1995:152:778-783.
16. Aronson SC. Black JE, McDougle CJ, Scanley BE, Jatlow BE, Kosten TR. Henniger GR. Price L: Serotonergic mechanisms of cocaine effects in humans. Psychopharmacology 1993:119:179-185.
17. Summers KL. Giacobini E: Effects of local and repeated systemic administration of nicotine on extracellular levels of acetylcholine, norepinephrine, dopamine and serotonin in rat cortex. Neurochem Res 1995; 20:753-759.
18. Riekkincn P Jr. Sirvió J. Rickkinen M: Serotonin depletion decreases the therapeutic effects of nicotine but THA in medial septal-lcsioncd rats. Brain Res 1994;662:95-102.
19. Hitzig P: Combined dopamine and agonists: A synergistic approach to alcoholism and other additive behaviors. Md Med J 1993:42:153-156.
20. Grimsley SR. Jann MW: Fluoxetine, sertraline and fluvoxaminc: New selective serotonin rcuptake inhibitors. Clin Pharmacol 1992:11: 930-957.
21. Schreiber R. DeVry J: Neuroana-tomical correlates of anxiolytic effects of the 5-HT IA receptor ligand 8-H-DpAT. ipsapirone and buspi-rone in the rat. Psychopharmacology 1990:101:52-59.
22. Bcrrcttini WH. Ferraro TN. Alexander RC. Buchsberg AM. Vogel WH: Quantitative trait loci mapping of three loci controlling morphine preference using inbred strains of mice. Nat Genet 1994:7:54-58.
23. Berrettini WH, Alexander RC. Ferraro TN. Vogel WH: A study of oral preference in inbred mouse. Psy-chiatrGenet 1994:4:81-86.
24. Alexander RC. Duda J. Garth D, Vogel WH. Berrettini WH: Morphine and cocaine preference in inbred mice. Psychiatr Genet 1993: 3:33-37.
25. Taylor J. Harris N, Vogel WH: Voluntary alcohol and cocaine consumption in low and high stress plasma catecholamine responding rats. Pharmacol Biochem Bchav 1990;37:359-363.
26. Gill K. Amit Z: Serotonin uptake blockers and voluntary alcohol consumption. Recent Dev Alcohol 1989;7:225-248.
27. Lu MR, Wagner GC. Fisher H: Ethanol consumption following acute fenfluramine, fluoxetine and dietary tryptophan. Pharmacol Biochem Bchav 1993;44:931-937.
28. Yoshimoto K, Kawantura K. Fuji-miya T. Uemura K. Komura S: The effects of neurotoxins 6-hydroxydo-pamine and 5.7-dihydroxytrypt-aminc into the rat nucleus accumb-ens on the alcohol drinking behavior. Nippon Hoigaku Zasshi 1995; 49:11-19.
29. Tomkins DM. Higgins GA, Sellers EM: Low doses of the 5-HT agonist 8-hydroxy-2-(di-n-propylamino)ter-alin increase ethanol intake. Psychopharmacology 1994; 115:173-179.
30. Rammsayer T. Vogel WH: Ritanser-in and voluntary intake of alcohol. Integr Physiol Bchav Sci 1994;29: 411-415.
31. Spyraki C. Nomikos GG. Galano-poulou P, Daifotis Z: Drug induced placement preference in rats with lesions of the nucleus accumbens. Bchav Brain Res 1988:29:127-134.
32. Carboni E, Acquas E. Leone P. Di Chiara G: 5-HT3 receptor antagonists block morphine-and nicotine-, but not amphetamine-induced reward. Psychopharmacol 1989;97: 175-178.
33. Britton DR, Curzon P. Mackenzie RG. Kebabian JW, Williams JE. Kerkman D: Evidence for the involvement of both DI and D2 receptors in maintaining cocaine self-administration. Psychopharmacology 1993;119:123-129.
34. Hadftcld MG: Cocaine, selective regional effects on central monoamines. Mol Neurobiol 1995:11:47-53.
35. Corrigall WA. Coen KM: Nicotine self-administration and locomotor activity are not modified by the 5-HT3 antagonist ICS 205-930 and MDL 72222. Pharmacol Biochem Behav 1994:49:67-71.
36. Naranjo CA. Poulos CX. Bremner KE, Lanctot KL: Citalopram decreases desirability, liking and consumption of alcohol in alcohol-de-pendent drinkers. Clin Pharmacol Ther 1992:451:729-739.